Chardonnet Laurent
SEC CIK 1329010 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | CFO | 42.2K | $117.4K | — | 5 | 2021-12-13 | 2023-05-23 |
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Chardonnet Laurent made no open-market trades at PRLD in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | 2023-05-23 | PRLD | Prelude Therapeutics Inc | Chardonnet Laurent | CFO | P - Purchase | $5.50 | +5,000 | 42.2K | +13% | +$27.5K | |
| 2022-12-12 | 2022-12-08 | PRLD | Prelude Therapeutics Inc | Chardonnet Laurent | CFO | P - Purchase | $4.76 | +10.0K | 35.9K | +39% | +$47.6K | |
| 2022-06-01 | 2022-06-01 | PRLD | Prelude Therapeutics Inc | Chardonnet Laurent | CFO | P - Purchase | $4.23 | +10.0K | 24.5K | +69% | +$42.3K | |
| 2022-03-22 | 2022-03-21 | PRLD | Prelude Therapeutics Inc | Chardonnet Laurent | CFO | A - Grant | $7.51 | +6,500 | 14.5K | +81% | +$48.8K | |
| 2021-12-14 | 2021-12-13 | PRLD | Prelude Therapeutics Inc | Chardonnet Laurent | CFO | A - Grant | $12.28 | +5,000 | 8,000 | +167% | +$61.4K |
Purchase Sale Sale after option exercise All abbreviations